» Articles » PMID: 10969152

Effects of a BLT Receptor Antagonist on Local and Remote Reperfusion Injuries After Transient Ischemia of the Superior Mesenteric Artery in Rats

Overview
Journal Eur J Pharmacol
Specialty Pharmacology
Date 2000 Sep 2
PMID 10969152
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Reperfusion of ischemic vascular beds may lead to recruitment and activation of leukocytes, release of mediators of the inflammatory process and further injury to the affected vascular bed and to remote sites. Neutrophils appear to play a major role in the pathophysiology of reperfusion injury. Amongst inflammatory mediators shown to activate neutrophils and induce their recruitment in vivo, much interest has been placed on the role of leukotriene (LT)B(4). Here, we have assessed the effects of the BLT receptor antagonist (+)-1-(3S, 4R)-[3-(4-phenyl-benzyl)-4-hydroxy-chroman-7-yl]-cyclopentane carboxylic acid (CP 105,696) in a model of neutrophil-dependent ischemia and reperfusion injury in the rat. The superior mesenteric artery was isolated and ischemia was induced by its total occlusion for 30 min. After 30 min of reperfusion, injury was assessed by evaluating the extravasation of Evans blue, an index of vascular permeability, and the levels of myeloperoxidase, an index of neutrophil accumulation, in the intestine, mesentery and lung. The neutrophil-dependence of the local (intestine and mesentery) and remote (lung) injury was confirmed by using fucoidin, a selectin blocker, and WT-3, an anti-CD18 monoclonal antibody. Post-ischemic treatment with CP 105,696 dose-dependently inhibited vascular permeability and neutrophil accumulation in the intestine and mesentery. CP 105,696 also blocked the vascular permeability changes, but not neutrophil accumulation, in the lungs after reperfusion injury. Virtually identical results were obtained with another BLT receptor antagonist, 1-(5-ethyl-2-hydroxy-4-(6-methyl-6-(1H-tetrazol-5-yl)-heptoxy++ +)-phenyl )ethanone (LY255283). Our results suggest that post-ischemic treatment with BLT receptor antagonists may inhibit local and remote ischemia and reperfusion injury by blocking both the accumulation and/or activation of neutrophils.

Citing Articles

Angioedema and Fatty Acids.

Wada A, Sawada Y, Sugino H, Nakamura M Int J Mol Sci. 2021; 22(16).

PMID: 34445711 PMC: 8396478. DOI: 10.3390/ijms22169000.


The Gut-Lung Axis in Systemic Inflammation. Role of Mesenteric Lymph as a Conduit.

Ma Y, Yang X, Chatterjee V, Wu M, Yuan S Am J Respir Cell Mol Biol. 2020; 64(1):19-28.

PMID: 32877613 PMC: 7781004. DOI: 10.1165/rcmb.2020-0196TR.


Systemic leukotriene B receptor antagonism lowers arterial blood pressure and improves autonomic function in the spontaneously hypertensive rat.

Marvar P, Hendy E, Cruise T, Walas D, DeCicco D, Vadigepalli R J Physiol. 2016; 594(20):5975-5989.

PMID: 27230966 PMC: 5063948. DOI: 10.1113/JP272065.


Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo.

Colom B, Bodkin J, Beyrau M, Woodfin A, Ody C, Rourke C Immunity. 2015; 42(6):1075-86.

PMID: 26047922 PMC: 4504024. DOI: 10.1016/j.immuni.2015.05.010.


Pharmacological inhibition of CXCR2 chemokine receptors modulates paraquat-induced intoxication in rats.

Costa K, Maciel I, Kist L, Campos M, Bogo M PLoS One. 2014; 9(8):e105740.

PMID: 25153082 PMC: 4143277. DOI: 10.1371/journal.pone.0105740.